FCF1P2: A Drug Target / Disease Biomarker (G101060195)

Target Name: FCF1P2

NCBI ID: G101060195

FCF1P2

Other Name(s): FCF1 pseudogene 2

FCF1P2: A Drug Target / Disease Biomarker

FCF1P2, also known as NG2, is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the T-cell antigen receptor (TCR) family and is involved in the regulation of cell growth, differentiation, and survival. FCF1P2 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, FCF1P2 has become a focus of interest for researchers as a potential drug target or biomarker.

FCF1P2 is a 21-kDa protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the T-cell antigen receptor (TCR) family and is involved in the regulation of cell growth, differentiation, and survival. The FCF1P2 protein is composed of two distinct chains, A and B, that are held together by a disulfide bond.

FCF1P2 is highly conserved across various species, with only minor differences in its amino acid sequence. It is expressed in a variety of tissues and is involved in several physiological processes, including cell growth, differentiation, and survival. For example, FCF1P2 has been shown to play a role in the regulation of cell proliferation and differentiation. It has been shown to inhibit the activity of the oncogene transforming growth factor (TGF-2), which is involved in the development and progression of various diseases, including cancer.

In addition to its role in cell growth and differentiation, FCF1P2 has also been shown to be involved in the regulation of cell survival. Studies have shown that FCF1P2 can induce the expression of genes that are involved in cell survival, such as the tumor suppressor gene p53. This suggests that FCF1P2 may play a role in the development and progression of cancer by inhibiting the ability of cells to survive.

FCF1P2 has also been shown to be involved in the regulation of immune responses. Studies have shown that FCF1P2 can modulate the activity of T cells, which are a critical part of the immune system. This suggests that FCF1P2 may play a role in the development and regulation of various immune-related diseases.

In addition to its role in immune regulation, FCF1P2 has also been shown to be involved in the regulation of cell signaling pathways. Studies have shown that FCF1P2 can interact with several different signaling pathways, including the PI3K/Akt signaling pathway. This suggests that FCF1P2 may play a role in the regulation of cellular signaling pathways and their associated diseases.

FCF1P2 has also been shown to be involved in the regulation of cellular interactions with the extracellular matrix (ECM). Studies have shown that FCF1P2 can interact with several different ECM components, including collagen and laminin. This suggests that FCF1P2 may play a role in the regulation of cellular interactions with the ECM and their associated diseases.

In conclusion, FCF1P2 is a protein that is involved in several physiological processes and has been shown to play a role in the development and progression of various diseases. As a result, FCF1P2 has become a focus of interest for researchers as a potential drug target or biomarker. Further research is needed to fully understand the role of FCF1P2 in various biological processes and to determine its potential as a therapeutic agent.

Protein Name: FCF1 Pseudogene 2

The "FCF1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FCF1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets